Skip to main content

Table 1 Clinical and CMR characteristics of patients with HCM and genetically positive for MYBPC3 or MYH7.

From: Myocardial fibrosis comparison by cmr between genetically positive HCM patients with MYBPC3 and MYH7 gene mutations

 

All (n=57)

MYBPC3

MYH7

P-value

Age, years ± SD

36.8 ± 12.3

36.5 ± 12.2

37.2 ± 12.6

0.84

Male, n (%)

37 (64.9)

16 (66.6)

21 (63.4)

0.64

LVEF, % ± SD

71.1 ± 10.9

72.9 ± 8.5

69.6 ± 12.5

0.53

LV mass, g ± SD

207.5 ± 70.4

216.7 ± 72.9

202.2 ± 69.8

0.54

Thickness, mm ± SD

23.9 ± 6.9

22.7 ± 1.69

25.1 ± 1.24

0.24

Fibrosis (%)

11.0 ± 9.7

11.0 ± 2.39

11.0±1.44

0.38

Fibrosis, g ± SD

21.6 ± 21.0

21.4 ± 25.3

21.7 ± 17.8

0.47